Study protocol of the hyper-liv01 trial: a multicenter phase ii, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

HIGHLIGHTS

  • who: Emmanuel Deshayes from the Department of Radiology, Saint Eloi University Hospital, Augustin Fliche, Montpellier, France have published the research: Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases, in the Journal: (JOURNAL)
  • what: The aim of this randomized phase II trial is to compare the percentage of change in FLR volume at 3 weeks after LVD or PVE.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?